Glucose Monitoring Insulin Administration - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Glucose Monitoring Insulin Administration

Description:

Redness, swelling, tenderness at injection site 1-2 hrs after injection ... Treat by losing weight and by giving more concentrated insulins or steroids ... – PowerPoint PPT presentation

Number of Views:666
Avg rating:3.0/5.0
Slides: 32
Provided by: jacqu
Category:

less

Transcript and Presenter's Notes

Title: Glucose Monitoring Insulin Administration


1
Glucose MonitoringInsulin Administration
2
  • Blood glucose monitoring is a cornerstone of
    diabetes management
  • Self Monitoring of blood glucose (SMBG) enables
    optimum control

3
SMBG
  • Various methods available
  • Use whole blood or plasma
  • Obtain drop of blood from fingertip or forearm
  • Apply blood to special reagent strip
  • Meter gives a digital readout

4
Sources of Error
  • Improper application of blood
  • Improper meter cleaning and maintenance
  • Damage to reagent strips by heat or humidity
  • Use of outdated strips

5
Values for Normal Blood
Glucose
  • Smeltzer - 60 - 100 mg/dL
  • Fischbach - 65 - 110 mg/dl

6
Other Methods To Test Glucose
  • Visual method
  • Urine glucose testing

7
Disadvantages to Urine Glucose Testing
  • Does not accurately reflect blood glucose level
    at the time of test
  • Renal threshold for glucose is 180 - 200 mg/dL
  • Hypoglycemia can not be detected
  • Various drugs interfere with results

8
Testing for Ketones
  • Ketone bodies are byproducts of fat breakdown
  • Occurs when insulin is not available for cells to
    utilize glucose
  • Methods of testing
  • Ketostix
  • Meter
  • Should be performed when SMBG levelsgt240 mg/dL

9
Points to Remember When Checking Blood Glucose
  • Follow universal precautions
  • Wash clients hands with warm soap and water
  • Prick outer edge of finger
  • Touch reagent pad to finger only once
  • Keep record or log

10
Frequency of SMBG
  • Clients receiving insulin - 2 - 4 X day
  • Clients not receiving insulin - 2 -3 X week
  • Test whenever hypoglycemia or hyperglycemia
    suspected

11
Antidiabetic drugs are
  • Used primarily to control diabetes mellitus, a
    chronic disease that affects carbohydrate
    metabolism
  • Two groups of antidiabetic drugs

12
Insulin
  • Released from beta cells of the islets of
    Langerhans
  • Facilitates the uptake and utilization of glucose
    by the cells
  • Exogenous insulin previously produced from pork
    and bovine pancreas
  • Currently produced by recombinant DNA technology
  • Different types of insulin

13
(No Transcript)
14
Important Points to Remember About Insulin
  • Grouped based on onset, peak, duration
  • Rapid and short acting insulins are clear
  • Intermediate and long acting insulins are cloudy,
    except Lantis
  • Lantis is clear, taken at bedtime and can not be
    mixed with other insulins
  • Encourage patients to keep a spare bottle in the
    refrigerator

15
Storage of Insulin
  • Unopened vials are refrigerated until expiration
    date
  • Once opened, vial may be stored
  • At room temp X 1 month
  • In refrig X 3 months
  • Prefilled syringes X 3 weeks

16
  • Avoid storage areas near direct sunlight or heat
  • Never freeze insulin

17
Insulin Regimens
  • May receive if Type 1 or Type 2
  • Varies from client to client
  • Usually 1 - 4 injections daily
  • Usually a combination of rapid/short acting and
    longer acting
  • May have set dose of daily insulin
  • Frequently have sliding scale coverage for
    elevated glucose levels

18
(No Transcript)
19
(No Transcript)
20
(No Transcript)
21
Rotating Injection Sites
  • Recommended to prevent localized changes in fatty
    tissue
  • Four main areas for injection
  • Abdomen
  • Posterior arms
  • Anterior thighs
  • Hips

22
  • Do not inject in a limb to be exercised
  • ADA recommends using all available injection
    sites within one area
  • Another approach use same area at same time of
    day
  • Administer 1 away from previous site
  • Do not use same site more than once in 2-3 weeks

23
Complications of Insulin Therapy
  • Local allergic reactions
  • Redness, swelling, tenderness at injection site
    1-2 hrs after injection
  • Less common with human insulins
  • Disappears in time
  • Physician may prescribe antihistamines 1 hr
    before injection

24
  • Systemic allergic reactions
  • Rare
  • Immediate local skin reaction which progresses to
    urticaria
  • Occasionally generalized edema and anaphylaxis
  • Treat with desensitization

25
  • Lipodystrophy
  • Lipoatrophy - loss of fat tissue that appears as
    dimpling or pitting
  • Lipohypertrophy - development of fibrofatty masses

26
  • Insulin resistance - large amounts of insulin are
    required to control glucose.
  • Contributing factors
  • Obesity
  • Animal insulins
  • Treat by losing weight and by giving more
    concentrated insulins or steroids

27
  • Hypoglycemia - abnormally low glucose levels
    usually less than 60mg/dL
  • Causes
  • Too much insulin or oral hypoglycemic meds
  • Too little food or delayed meal
  • Excessive physical activity

28
Clinical Manifestations of Hypoglycemia
  • Mild hypoglycemia
  • Sweating
  • Tremors
  • Tachycardia, palpitations
  • Hunger

29
  • Moderate hypoglycemia
  • Headache
  • Lightheadedness
  • Confusion
  • Slurred speech
  • Impaired co-ordination
  • Blurred vision
  • Numbness of lips and tongue

30
  • Severe hypoglycemia
  • Disoriented behavior
  • Difficulty arousing
  • Seizures
  • Coma and death

31
Treatment of Hypoglycemia
  • Assess client
  • Check glucose with meter
  • Administer 15 gms of fast acting carbohydrate
  • 3 glucose tablets
  • 4 oz of fruit juice or soda
  • 1 cup skim milk
  • 1 tbsp honey or sugar
  • Retest glucose in 15 minutes
  • If less than 70-75 mg, repeat CHO
  • Administer snack with protein and starch or eat
    regular meal
Write a Comment
User Comments (0)
About PowerShow.com